
IDEXX Laboratories (IDXX) Stock Forecast & Price Target
IDEXX Laboratories (IDXX) Analyst Ratings
Bulls say
IDEXX Laboratories is a global leader in animal health diagnostics and software. It has a strong recurring revenue model with over 35% of its revenue coming from outside the United States, and its core companion animal segment represents over 90% of its total revenue. It has consistently outperformed industry averages for revenue growth and has a strong customer retention rate of around 97%. The stock may trade at a premium valuation, but IDEXX's strong performance and position in the market make it a solid long-term investment opportunity.
Bears say
IDEXX Laboratories is a leading veterinary diagnostics company, but faces risks including competition, complex manufacturing, government regulation, consolidation, inexperience in human diagnostics, and potential impact from macroeconomic headwinds. Despite potential easing of these issues, clinical office visits continue to decline, and the company faces challenges with staffing shortages and inflation that may impact growth. Additionally, while IDEXX has a large and productive salesforce and continues to invest in R&D, there is some degree of competition in the animal health industry.
This aggregate rating is based on analysts' research of IDEXX Laboratories and is not a guaranteed prediction by Public.com or investment advice.
IDEXX Laboratories (IDXX) Analyst Forecast & Price Prediction
Start investing in IDEXX Laboratories (IDXX)
Order type
Buy in
Order amount
Est. shares
0 shares